Synopsis
Use the current UK immunisation programme and layered infection-prevention measures to reduce serious respiratory, shingles, pneumococcal and care-associated disease while adapting consent, timing, contraindications and delivery for frailty and care settings.
- Check the live UK routine schedule and Green Book at every review because age cohorts, products and seasonal eligibility can change.
- Offer annual influenza vaccination to current eligible older adults and risk groups before the main season, without missing later opportunities.
- COVID-19 vaccination follows the current seasonal JCVI and national campaign; do not assume last year's age threshold or product.
- The adult RSV programme offers a single dose at the routine age and current catch-up cohort, with eligibility confirmed from the live schedule.
- Shingrix is a non-live two-dose shingles vaccine used in the current age and immunosuppressed cohorts, with interval determined by immune status.
- Offer the current national pneumococcal vaccine to eligible age and clinical-risk groups and verify prior doses, as programme product can change.
- First-line vaccine assessment checks records, age and risk eligibility, immune suppression, pregnancy where relevant, allergy phenotype, acute illness and consent.
- Mild illness is not usually a reason to defer; defer significant acute febrile illness when appropriate and rebook with named follow-through.
- Infection prevention layers vaccination with hand and respiratory hygiene, ventilation, cleaning, device care, PPE by risk and antimicrobial stewardship.
- Care-home outbreak plans require early recognition, line listing, testing, health-protection advice, staffing and proportionate isolation that preserves nutrition, movement and communication.
Key red flags
Airway swelling, wheeze, hypotension or collapse after vaccination requires immediate anaphylaxis treatment and emergency transfer.
New hypoxia, confusion, hypotension or reduced urine during an outbreak requires individual sepsis and respiratory assessment.
Vesicular rash with eye involvement, widespread lesions or immunosuppression requires urgent shingles complication assessment.
Fever and rapidly progressive non-blanching rash or meningism requires emergency meningococcal treatment and notification.
Multiple linked respiratory or diarrhoeal cases in a care setting requires prompt outbreak reporting and coordinated control.
A previous true anaphylactic reaction to a vaccine component requires specialist assessment rather than routine administration or blanket avoidance.
Rapid airway, breathing or circulation compromise after administration requires immediate intramuscular adrenaline.
Linked respiratory or gastrointestinal illness affects residents or staff over a compatible period.
Sepsis physiology, eye shingles, meningism or widespread infection in immune suppression requires urgent treatment.
Investigation priorities
Identify missing doses and avoid duplication.
Management branches
An older adult attends a routine, chronic-disease or care-setting review.
- Check verified records against the live UK schedule and current seasonal, age and clinical-risk eligibility.
- Assess contraindications, immune status, timing and consent and explain benefits, common reactions and important warning signs.
- Administer or book eligible doses, record product and batch in all relevant systems and recall for course completion.